Fulton Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-659
Closed -$216K 642
2024
Q4
$216K Sell
659
-11
-2% -$3.73K 0.01% 620
2024
Q3
$224K Buy
+670
New +$213K 0.01% 611
2024
Q2
Sell
-702
Closed -$243K 633
2024
Q1
$243K Buy
+702
New +$231K 0.01% 550
2023
Q3
Sell
-559
Closed -$212K 571
2023
Q2
$212K Sell
559
-12
-2% -$4.88K 0.01% 522
2023
Q1
$274K Buy
571
+76
+15% +$35.6K 0.01% 456
2022
Q4
$208K Buy
495
+1
+0.2% +$404 0.01% 493
2022
Q3
$206K Buy
494
+35
+8% +$17.4K 0.01% 454
2022
Q2
$227K Sell
459
-16
-3% -$8.33K 0.01% 438
2022
Q1
$267K Sell
475
-65
-12% -$39.2K 0.01% 439
2021
Q4
$408K Buy
540
+10
+2% +$7.48K 0.02% 376
2021
Q3
$396K Buy
530
+6
+1% +$4.5K 0.02% 358
2021
Q2
$338K Buy
524
+10
+2% +$6.09K 0.02% 373
2021
Q1
$293K Buy
514
+66
+15% +$39.1K 0.01% 383
2020
Q4
$261K Buy
448
+28
+7% +$15.9K 0.01% 380
2020
Q3
$217K Buy
+420
New +$213K 0.01% 398

Other funds holding BIO